share_log

Genius Group | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Genius Group | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Genius Group | F-1/A:證券登記表(修正)
美股SEC公告 ·  08/15 22:22
牛牛AI助理已提取核心訊息
Genius Group Limited (GNS) has announced the immediate exercise of certain outstanding Series 2024-C warrants to purchase up to 10,950,451 of the company's ordinary shares at a price of $0.35 per share. The exercise is expected to generate approximately $3.8 million in gross proceeds for the company, before deducting placement agent fees and estimated offering expenses. In exchange for the immediate cash exercise of the warrants, Genius Group will issue new unregistered Series 2024-D and Series 2024-E warrants to purchase up to 10,950,451 ordinary shares each. The Series 2024-D warrants will have a term of five and a half years, and the Series 2024-E warrants will have a term of two years from the issuance date. Additionally, the company has agreed to amend...Show More
Genius Group Limited (GNS) has announced the immediate exercise of certain outstanding Series 2024-C warrants to purchase up to 10,950,451 of the company's ordinary shares at a price of $0.35 per share. The exercise is expected to generate approximately $3.8 million in gross proceeds for the company, before deducting placement agent fees and estimated offering expenses. In exchange for the immediate cash exercise of the warrants, Genius Group will issue new unregistered Series 2024-D and Series 2024-E warrants to purchase up to 10,950,451 ordinary shares each. The Series 2024-D warrants will have a term of five and a half years, and the Series 2024-E warrants will have a term of two years from the issuance date. Additionally, the company has agreed to amend existing warrants issued in April 2024, reducing the exercise price to $0.35 per share and issuing an additional 6,000,000 warrants to the holder. The offering closed on May 22, 2024, and the company intends to use the net proceeds for general corporate purposes, including working capital, operating expenses, debt repayment, and support for acquired assets. The shares underlying the warrants are registered under an effective registration statement on Form F-1. The company has not disclosed any plans to list the new warrants on any national securities exchange or other trading system.
Genius Group Limited(GNS)已宣佈立即行使某些未解決的2024-C系列認購權,以購買公司普通股中多達10,950,451股股票,價格爲每股0.35美元。預計此次行使將爲公司帶來約380萬美元的總票據收入,扣除發行代理費和預計發行費用。作爲立即行使認股權的交換,Genius Group將發行新的未註冊的2024-D和2024-E系列認股權,分別可以購買多達10,950,451股普通股。2024-D認股權的期限爲五年半,2024-E認股權的期限爲發行日起兩年。此外,該公司已同意修改在2024年4月發行的現有認股權,將行使價格降至每股0.35美元並向持有人發行額外的6,000,000份認股權。發行於2024年5月22日,並打算將淨收益用於一般公司用途,包括運營費用、營業費用、債務償還以及對收購資產的支持。認股權基礎股票在符合F-1表格的有效註冊聲明下注冊。該公司尚未透露計劃將新認股權列入任何國家證券交易所或其他交易系統。
Genius Group Limited(GNS)已宣佈立即行使某些未解決的2024-C系列認購權,以購買公司普通股中多達10,950,451股股票,價格爲每股0.35美元。預計此次行使將爲公司帶來約380萬美元的總票據收入,扣除發行代理費和預計發行費用。作爲立即行使認股權的交換,Genius Group將發行新的未註冊的2024-D和2024-E系列認股權,分別可以購買多達10,950,451股普通股。2024-D認股權的期限爲五年半,2024-E認股權的期限爲發行日起兩年。此外,該公司已同意修改在2024年4月發行的現有認股權,將行使價格降至每股0.35美元並向持有人發行額外的6,000,000份認股權。發行於2024年5月22日,並打算將淨收益用於一般公司用途,包括運營費用、營業費用、債務償還以及對收購資產的支持。認股權基礎股票在符合F-1表格的有效註冊聲明下注冊。該公司尚未透露計劃將新認股權列入任何國家證券交易所或其他交易系統。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。